Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2025-12-25 @ 1:18 AM
NCT ID:
NCT02137993
Eligibility Criteria:
Inclusion Criteria:
* 20 years to 65 years
* Schizophrenia patient with an acute exacerbation
* Understand the requirement of the study and voluntarily consent to participate in the study
Exclusion Criteria:
* Patients who have another psychiatric disorders
* Patients who have unstable medical conditions
* Patients who have clinically important abnormalities of liver function test (\>2.5 fold of upper normal limit), ECG and vital sign at screening visit
* Uncontrolled diabetic patients (plasma glucose level is more than 126 mg/dl in fasting condition)
* Patients who have a history of an allergic reaction to olanzapine
* Patient who have no clinical response to take two or more different atypical anti-psychotics for more than 4 weeks.
* Patient who take clozapine within 12 weeks before screening visit
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
65 Years
Study:
NCT02137993
Study Brief:
Protocol Section:
NCT02137993